Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Total Liabilities (Quarterly) : 17.47M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.47M |
| March 31, 2026 | 16.83M |
| December 31, 2025 | 21.10M |
| September 30, 2025 | 17.60M |
| June 30, 2025 | 15.62M |
| March 31, 2025 | 17.90M |
| Date | Value |
|---|---|
| December 31, 2024 | 19.10M |
| September 30, 2024 | 15.45M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 17.79M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.175B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Immunic, Inc. | 31.59M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 283.25M |
| Shareholders Equity (Quarterly) | 265.78M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 20.05 |
| Net Debt Paydown Yield | 0.01% |